4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 02-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -14 | -20 | N/A | N/A |
| Other Working Capital | -15 | -60 | N/A | N/A |
| Other Operating Activity | -425 | -210 | 0 | 0 |
| Operating Cash Flow | $-455 | $-290 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Purchase Of Investment | -40,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -40,000 | 0 | 0 |
| Investing Cash Flow | $-40,000 | $-40,000 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 202 | N/A | N/A | N/A |
| Debt Repayment | -202 | N/A | N/A | N/A |
| Common Stock Issued | 41,525 | N/A | N/A | N/A |
| Other Financing Activity | -431 | 41,090 | 0 | 0 |
| Financing Cash Flow | $41,094 | $41,090 | $N/A | $N/A |
| End Cash Position | 639 | 800 | N/A | N/A |
| Net Cash Flow | $639 | $800 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -455 | -290 | N/A | N/A |
| Free Cash Flow | -455 | -290 | 0 | 0 |